Molecular and Clinical Profiles of Human Pegivirus Type 1 Infection in Individuals Living with HIV-1 in the Extreme South of Brazil
Figure 2
Laboratory results of the pilot study. (a) Each line (1 to 10) corresponds to the laboratory results of a patient’s HPgV-1 test. The year of sample collection is represented in columns. Molecular HPgV-1 positivity is indicated by the + symbol and negativity by -. The red crosses indicate samples that have been tested until finding the positivity range. Purple crosses indicate samples that have been tested as internal quality controls of the positivity range. Blue crosses indicate samples that have not been tested, because the positivity interval had already been estimated. Green crosses indicate samples that have been tested in a previous study that identified HPgV-1/HIV-1 coinfections [11]. The X’s indicate unavailable samples. (b) The graph illustrates the standard criterion established for the test. The red arrows indicate the time direction of the samples to be tested until the positivity range indicated by the blue line is determined.